Loading...
NYSE: EW
Edwards Lifesciences Corporation
Healthcare · Medical - Devices
●S&P 500 since 2011
Market Cap
$47.95B
52w High
$87.89
52w Low
$65.94
P/E
44.78
Volume
1.61M
Outstanding Shares
580.80M
Company profile
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally.
CEOBernard J. Zovighian
SectorHealthcare
IndustryMedical - Devices
Employees15,800
IPO dateMar 27, 2000
Valuation
Forward P/E—
EV/EBITDA33.31
Enterprise value$47.62B
Stock splits
Jun 1, 20203:1
Dec 14, 20152:1
May 28, 20102:1
Profitability & growth
Revenue growth13.26%
Gross margin78.11%▼1.67%vs FY2024
Operating margin26.72%▲6.39%vs FY2024
ROE10.38%▼75.13%vs FY2024
Analyst consensus
RatingBuy
Target price$96.38▲16.75%
32
Buy
16
Hold
0
Sell
⚠ Analyst ratings tend to be lagging indicators — upgrades often follow price gains rather than precede them. Use as one signal among many.
Earnings
Last 3 reported quarters plus the next estimate. Switch into compare mode to inspect one metric year-over-year.
Next report
Apr 22, 2026
View
EPS
Actual vs estimate by quarter
Q2FY25
ActualEst.
$0.67
$0.62
Q3FY25
ActualEst.
$0.67
$0.60
Q4FY25
ActualEst.
$0.58
$0.62
Q1FY26
Next Est.
—
Revenue
Actual vs estimate by quarter
Q2FY25
ActualEst.
$1.53B
$1.49B
Q3FY25
ActualEst.
$1.55B
$1.5B
Q4FY25
ActualEst.
$1.57B
$1.55B
Q1FY26
Next Est.
—